Illumina Fails To Shred Syntrix DNA Patent After $96M Verdict
A Washington federal judge on Friday affirmed the validity of a Syntrix Biosystems Inc. patent covering DNA technology that a jury previously found was infringed by competitor Illumina Inc. as part...To view the full article, register now.
Already a subscriber? Click here to view full article